Positions

Overview

  • Dr. Edward Hook III is Professor of Medicine and Epidemiology and Director of the STD Control Program for the Jefferson County (Alabama) Department of Health.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Kissing, saliva exchange, and transmission of Neisseria gonorrhoeae 2019
    2019 The National Network of Sexually Transmitted Disease Clinical Prevention Training Centers Turns 40-A Look Back, a Look Ahead 2019
    2019 Delay in Seeking Health Care Services after Onset of Urethritis Symptoms in Men 2019
    2019 Efficacy and Safety of Single-Dose Oral Delafloxacin Compared with Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study 2019
    2019 Detection of chlamydia trachomatis and neisseria gonorrhoeae with the cobas CT/NG v2.0 test: Performance compared with the BD ProbeTec CT Q x and GC Q x amplified DNA and Aptima AC2 assays 2019
    2019 Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-Associated mutations in heterosexual african American couples in Alabama 2019
    2018 Microbiological analysis from a phase 2 randomized study in adults evaluating single oral doses of gepotidacin in the treatment of uncomplicated urogenital gonorrhea caused by neisseria gonorrhoeae 2018
    2018 Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea 2018
    2018 A Brief History of Evolving Diagnostics and Therapy for Gonorrhea: Lessons Learned 2018
    2018 Defining the Urethritis Syndrome in Men Using Patient Reported Symptoms 2018
    2018 Health Risks of American Long-Distance Truckers: Results From a Multisite Assessment 2018
    2018 Is There a Continuum of Risk for Sexually Transmitted Infections among African American Women? 2018
    2017 Antimicrobial drug prescription and Neisseria gonorrhoeae susceptibility, United States, 2005–2013 2017
    2017 The Need to Promote Sexual Health in America: A New Vision for Public Health Action 2017
    2017 Continued evolution of gonococcal antimicrobial resistance 2017
    2017 Population-attributable fraction of tubal factor infertility associated with chlamydia 2017
    2017 Meatal swabs contain less cellular material and are associated with a decrease in gram stain smear quality compared to urethral swabs in men 2017
    2017 Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines 2017
    2017 Syphilis 2017
    2017 Sexually Transmitted Infection Risk among Women Is Not Fully Explained by Partner Numbers 2017
    2017 Stability studies on dry swabs and wet mailed swabs for detection of chlamydia trachomatis and neisseria gonorrhoeae in aptima assays 2017
    2017 Combined testing for chlamydia, gonorrhea, and trichomonas by use of the BD max CT/GC/TV assay with genitourinary specimen types 2017
    2017 Impact of eligibility criteria on participant enrollment for a randomized clinical trial of gonorrhea treatment 2017
    2017 Rate of Decline in Nontreponemal Antibody Titers and Seroreversion after Treatment of Early Syphilis 2017
    2017 Utilization of the Cepheid Xpert® CT/NG Sample Adequacy Control to Determine the Influence of the Urethral Swab on Cellular Content in Post-Swab versus Pre-Swab Urine 2017
    2016 A recommendation against serologic screening for genital herpes infection-what now? 2016
    2016 Chlamydia trachomatis infection in African American women who exclusively have sex with women 2016
    2016 Ocular Syphilis in Context 2016
    2016 Reported Church Attendance at the Time of Entry into HIV Care is Associated with Viral Load Suppression at 12 Months 2016
    2016 Neisseria gonorrhoeae antimicrobial susceptibility surveillance - The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014 2016
    2016 Predictors of HIV Disclosure in Infected Persons Presenting to Establish Care 2016
    2015 Sexual Health in America: Improving Patient Care and Public Health 2015
    2015 The role of early HIV status disclosure in retention in HIV care 2015
    2015 Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained from Women and Men 2015
    2015 The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2 2015
    2015 Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the united states by the gonococcal isolate surveillance project, 2005 to 2013 2015
    2015 A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea 2015
    2015 Evaluating the performance of the focus HerpeSelect<sup>®</sup> HSV-2 IgG in veterans with chronic hepatitis C infection 2015
    2015 Generalized Testing for Gonococcal Antibiotic Susceptibility or Sentinel Surveillance 2015
    2015 Performance of the BD CTQx and GCQx amplified assays on the BD Viper LT compared with the BD viper XTR system 2015
    2015 Sexual health in America: Improving patient care and public health 2015
    2015 Trends in neisseria gonorrhoeae susceptibility to cephalosporins in the United States, 2006-2014 2015
    2014 The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea 2014
    2014 A pilot study examining the safety and tolerability of valacyclovir in veterans with hepatitis c virus/herpes simplex virus type 2 coinfection 2014
    2014 Reply to rapose 2014
    2014 Church attendance in men who have sex with men diagnosed with HIV is associated with later presentation for HIV care 2014
    2014 HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (herpevac trial for women) 2014
    2014 Lower sexually transmissible infection prevalence among lifetime exclusive women who have sex with women compared with women who have sex with women and men 2014
    2014 Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection risk 2014
    2013 Evolving gonococcal antimicrobial resistance: Research priorities and implications for management 2013
    2013 Sexual history taking and sexually transmitted infection screening in patients initiating erectile dysfunction medication therapy 2013
    2013 Clinical evaluation of a new pap test-based method for screening of chlamydia trachomatis and neisseria gonorrhoeae using liquid-based cytology media 2013
    2013 Clinical management of early syphilis 2013
    2013 Impact of a computer-assisted, provider-delivered intervention on sexual risk behaviors in HIV-positive men who have sex with men (MSM) in a primary care setting 2013
    2013 Spontaneous resolution of genital chlamydia trachomatis infection in women and protection from reinfection 2013
    2013 Performance of the cepheid CT/NG Xpert rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae 2013
    2013 Misperceptions regarding protective barrier method use for safer sex among African-American women who have sex with women 2013
    2013 Remembering thomas parran, his contributions and missteps going forward: History informs us 2013
    2013 Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: The gonococcal isolate surveillance project, 2005-2010 2013
    2013 Sexual health training and education in the U.S. 2013
    2013 Vaginal swabs are the optimal specimen for detection of genital chlamydia trachomatis or neisseria gonorrhoeae using the cobas 4800 CT/NG test 2013
    2013 Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women 2013
    2013 Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin 2013
    2013 Serologic screening for herpes simplex virus type 2 in persons with human immunodeficiency virus 2013
    2012 Editorial commentary: A syphilis wish list: Better data, better tests 2012
    2012 Immunoglobulin-specific responses to chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection 2012
    2012 Predictors of undiagnosed herpes simplex virus type 2 seropositivity among persons attending an HIV care clinic 2012
    2012 Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test 2012
    2012 Pneumocystis pneumonia in hospitalized patients: A detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons 2012
    2012 Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in treponema pallidum in the United States, 2007 to 2009 2012
    2012 Update to CDC's sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections 2012
    2012 Factors related to increasing prevalence of resistance to ciprofl oxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States 2012
    2012 Rapid plasma reagin titer variation in the 2 weeks after syphilis therapy 2012
    2012 Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae 2012
    2012 Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital chlamydia trachomatis infection: A randomized, double-blind, double-dummy, active-controlled, multicenter trial 2012
    2012 Herpes diagnostic tests and their use 2012
    2012 Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents 2012
    2012 Reply to Keynan 2012
    2012 Bacterial Vaginosis, Gonorrhea, and Chlamydial Infection Among Women Attending a Sexually Transmitted Disease Clinic: A Longitudinal Analysis of Possible Causal Links 2012
    2012 CDC grand rounds: The growing threat of multidrug-resistant gonorrhea 2012
    2012 Clinical evaluation of the BD ProbeTec ™ Neisseria gonorrhoeae Q x Amplified DNA Assay on the BD Viper ™ System with XTR™ Technology 2012
    2012 A new look at genital herpes: the critical role of the laboratory in diagnosis and management. 2012
    2012 Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. 2012
    2012 Gender differences in risk for sexually transmitted diseases 2012
    2012 Prevalence and characteristics of herpes simplex virus type-2 coinfection in veterans with Hepatitis C 2012
    2011 Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis 2011
    2011 Cephalosporin susceptibility among Neisseria gonorrhoeae Isolates-United States, 2000-2010 2011
    2011 Clinical evaluation of the BD probetec™ chlamydia trachomatis Qx amplified DNA assay on the BD viper™ system with XTR™ technology 2011
    2011 Characteristics of women reporting multiple recent sex partners presenting to a sexually transmitted disease clinic for care 2011
    2010 HIV and Hepatitis B and C incidence rates in US correctional populations and high risk groups: A systematic review and meta-analysis 2010
    2010 Reply to Tarchini 2010
    2010 A Phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis 2010
    2010 Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections 2010
    2010 Herpes simplex virus in African American heterosexual males: The roles of age and male circumcision 2010
    2010 An evolving understanding of genital herpes pathogenesis: Is it time for our approach to therapy to change as well? 2010
    2009 Evaluation of azithromycin resistance in Treponema pallidum specimens from madagascar 2009
    2009 Risk behaviours in HIV-positive men who have sex with men participating in an intervention in a primary care setting 2009
    2009 High-risk behaviours among juvenile prison inmates in Pakistan 2009
    2009 Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. 2009
    2009 A 15-Minute interactive, computerized condom use intervention with biological endpoints 2009
    2008 Sexual risk behaviors and sexually transmitted infection prevalence in an outpatient psychiatry clinic 2008
    2008 Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic 2008
    2008 The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment 2008
    2008 HIV risk among long-haul truckers in the USA 2008
    2007 HIV discrimination and the health of women living with HIV 2007
    2007 Health-seeking behaviors and sexually transmitted diseases among adolescents attending an urban Pediatric Emergency Department 2007
    2007 Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in north American women by testing SurePath liquid-based pap specimens in APTIMA assays 2007
    2007 Update to CDC's sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections 2007
    2007 Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae 2007
    2006 A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera 2006
    2006 Why do we need quality-assured diagnostic tests for sexually transmitted infections? 2006
    2006 Why do we need quality-assured diagnostic tests for sexually transmitted infections? 2006
    2006 Sexually transmitted infections among urban shelter clients 2006
    2006 Time to translate new knowledge into practice: A call for a national genital herpes control program 2006
    2006 Efficacy of an HIV prevention program among female adolescents experiencing gender-based violence 2006
    2006 Health insurance coverage, health care-seeking behaviors, and genital chlamydial infection prevalence in sexually active young adults 2006
    2006 The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies 2006
    2006 The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic 2006
    2006 Vaginal douche practices among black women at risk: Exploring douching prevalence, reasons for douching, and sexually transmitted disease infection 2006
    2006 Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes 2006
    2006 The pathogenesis of syphilis: The Great Mimicker, revisited 2006
    2005 An intervention to reduce vaginal douching among adolescent and young adult women: A randomized, controlled trial 2005
    2005 Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections 2005
    2005 Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections 2005
    2005 An ounce of prevention 2005
    2005 A randomized trial of clinician-delivered interventions promoting barrier contraception for sexually transmitted disease prevention 2005
    2005 Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on gram stain: Implications for diagnostic approach and management 2005
    2005 Parents'/guardians' willingness to vaccinate their children against genital herpes 2005
    2005 Historical correlates of genital herpes simplex virus type 2 infection in men attending an STD clinic 2005
    2005 The cost effectiveness of gonorrhea screening in urban emergency departments 2005
    2005 Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness 2005
    2005 An intervention to promote the female condom to sexually transmitted disease clinic patients 2005
    2005 Confirming positive results of Nucleic Acid Amplification Tests (NAATs) for Chlamydia trachomatis: A11 NAATs are not created equal 2005
    2005 Relative cost-effectiveness of different tests for chlamydia trachomatis [2] (multiple letters) 2005
    2005 Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections 2005
    2005 Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs 2005
    2005 Female condom and male condom failure among women at high risk of sexually transmitted diseases 2005
    2005 Multicomponent Internet continuing medical education to promote chlamydia screening 2005
    2005 Public tolerance, private pain: Stigma and sexually transmitted infections in the American Deep South 2005
    2005 Sexually transmitted disease/HIV transmission risk behaviors and sexually transmitted disease prevalence among HIV-positive men receiving continuing care 2005
    2004 Screening for Chlamydia trachomatis in women 15 to 29 years of age: A cost-effectiveness analysis 2004
    2004 Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections 2004
    2004 Self-concept and adolescents' refusal of unprotected sex: A test of mediating mechanisms among African American girls 2004
    2004 Efficacy of an HIV prevention intervention for African American adolescent girls: A randomized controlled trial 2004
    2004 Syphilis control - A continuing challenge 2004
    2004 Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic 2004
    2004 Marginal validity of syndromic management for reproductive tract infections among pregnant women in Jamaica 2004
    2004 The Effect of Urine Testing in Evaluations of the Sensitivity of the Gen-Probe APTIMA® Combo 2 Assay on Endocervical Swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: The Infected Patient Standard Reduces Sensitivity of Single Site Evaluation 2004
    2004 Population-Based Genetic and Evolutionary Analysis of Chlamydia trachomatis Urogenital Strain Variation in the United States 2004
    2004 Risk-Taking and Health-Seeking Behavior in Men with a History of Urethritis: Is There a Learning Curve? 2004
    2004 A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. 2004
    2004 Condom use among low-income African American males attending an STD clinic 2004
    2003 Acceptability of Urine Screening for Neisseria gonorrheae and Chlamydia trachomatis in Adolescents at an Urban Emergency Department 2003
    2003 High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: Implications for screening and urethritis management 2003
    2003 Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis 2003
    2003 Sexually transmitted diseases 2003
    2003 Comparison of STD burden and risk among men with and without regular doctors attending a southern urban STD clinic 2003
    2003 A refined estimate of the average lifetime cost of pelvic inflammatory disease 2003
    2003 Prevalence and factors associated with gonorrhea and chlamydial infection in at-risk females presenting to an urban emergency department 2003
    2003 A prospective study of exposure to rap music videos and African American female adolescents' health 2003
    2003 Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2 2003
    2003 Demonstration of declining community prevalence of Chlamydia trachomatis infection using sentinel surveillance 2003
    2003 Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens 2003
    2002 Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea 2002
    2002 Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard 2002
    2002 Predictors of infection with Trichomonas vaginalis: A prospective study of low income African-American adolescent females 2002
    2002 Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States 2002
    2002 Association of adolescents' history of sexually transmitted disease (STD) and their current high-risk behavior and STD status: A case for intensifying clinic-based prevention efforts 2002
    2002 Preliminary evaluation of an immunochromatographic strip test for specific Treponema pallidum antibodies 2002
    2002 Hepatitis, syphilis, and HIV sentinel surveillance in Mongolia 1999-2000 [2] 2002
    2002 Low parental monitoring predicts subsequent pregnancy among African-American adolescent females 2002
    2002 Comparison of Digene Hybrid Capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens 2002
    2002 Psychosocial and behavioral correlates of refusing unwanted sex among African-American adolescent females 2002
    2002 A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis 2002
    2002 Associations between biologically confirmed marijuana use and laboratory-confirmed sexually transmitted diseases among African American adolescent females 2002
    2002 Condom use and correlates of African American adolescent females' infrequent communication with sex partners about preventing sexually transmitted diseases and pregnancy 2002
    2002 Douching beliefs and practices among black and white women 2002
    2002 Gang involvement and the health of African American female adolescents. 2002
    2002 Mass media as a population-level intervention tool for Chlamydia Trachomatis screening: Report of a pilot study 2002
    2002 Pregnant African-American teens are less likely than their nonpregnant peers to use condoms 2002
    2002 Prevalence and correlates of Chlamydia trachomatis among sexually active African-American adolescent females 2002
    2002 Psychosocial predictors of pregnancy among low-income African-American adolescent females: A prospective analysis 2002
    2002 Sexual risk behaviors associated with having older sex partners: A study of black adolescent females 2002
    2001 Correlates of casual sex among African-American female teens 2001
    2001 Relative accuracy of nucleic acid amplification tests and culture in detecting Chlamydia in asymptomatic men 2001
    2001 Urethral cytokine and immune responses in Chlamydia trachomatis-infected males 2001
    2001 Correct condom application among African-American adolescent females: The relationship to perceived self-efficacy and the association to confirmed STDs 2001
    2001 Parental monitoring: Association with adolescents' risk behaviors 2001
    2001 Correlates of using dual methods for sexually transmitted diseases and pregnancy prevention among high-risk african-american female teens 2001
    2001 Exposure to X-rated movies and adolescents' sexual and contraceptive-related attitudes and behaviors 2001
    2001 Socioeconomic status and self-reported gonorrhea among African American female adolescents 2001
    2001 Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs 2001
    2001 Condom carrying is not associated with condom use and lower prevalence of sexually transmitted diseases among minority adolescent females 2001
    2001 Correlates of Adolescent Females' Worry About Undesired Pregnancy: The Importance of Partner Desire for Pregnancy 2001
    2001 Gonorrhea in the HIV era: A reversal in trends among men who have sex with men 2001
    2001 HIV/STD-protective benefits of living with mothers in perceived supportive families: A study of high-risk African American female teens 2001
    2001 Modification of syphilitic genital ulcer manifestations by coexistent HIV infection 2001
    2001 Motorcycle taxi drivers and sexually transmitted infections in a Peruvian Amazon city 2001
    2001 Psychosocial correlates of adolescents' worry about STD versus HIV infection: Similarities and differences 2001
    2001 Self-obtained vaginal swabs for diagnosis of treatable sexually transmitted diseases in adolescent girls 2001
    2001 Single-dose gatifloxacin compared with ofloxacin for the treatment of uncomplicated gonorrhea: A randomized, double-blind, multicenter trial 2001
    2001 Validity of self-reported sexually transmitted diseases among african american female adolescents participating in an HIV/STD prevention intervention trial 2001
    2000 Evaluation of nucleic acid amplification tests as reference tests for chlamydia trachomatis infections in asymptomatic men 2000
    2000 Female Condom Use among Women at High Risk of Sexually Transmitted Disease 2000
    2000 Female condom use among women at high risk of sexually transmitted disease 2000
    2000 Partner type and condom use 2000
    2000 A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficieney virus-infected individuals 2000
    2000 Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics 2000
    2000 High prevalence of asymptomatic STDs in incarcerated minority male youth: A case for screening 2000
    2000 Opportunistic urine ligase chain reaction screening for sexually transmitted diseases in adolescents seeking care in an urban emergency department 2000
    2000 Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility 2000
    2000 Stages of readiness for changing multiple risk behaviors among incarcerated male adolescents 2000
    1999 Single-dose oral azithromycin for syphilis exposure? 1999
    1999 Ability of the Digene Hybrid Capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens 1999
    1999 High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers - Chicago, Birmingham, and San Francisco, 1998 1999
    1999 Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: Results from the gonorrhea community action project (GCAP) 1999
    1999 Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated chlamydial urethritis and cervicitis 1999
    1999 Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center 1999
    1999 Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis 1999
    1999 Detection of Chlamydia trachomatis endocervical infections by ligase chain reaction versus ACCESS Chlamydia antigen assay 1999
    1999 Trichomonas vaginalis - No longer a minor STD 1999
    1999 Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections 1999
    1999 Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic 1999
    1999 Self-reported sexual activity and condom use among symptomatic clients attending STD clinics 1999
    1999 Prevalence of gonococcal and chlamydial infections in commercial sex workers in a Peruvian Amazon City 1999
    1999 Under the influence: Risky sexual behavior and substance abuse among driving under the influence offenders 1999
    1999 HIV- 1(MN) recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1(MN) recombinant glycoprotein 120 vaccine 1999
    1999 Determinants of reinfection with Chlamydia trachomatis 1999
    1999 Elimination of syphilis transmission in the United States: historic perspectives and practical considerations. 1999
    1999 Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: High therapeutic success rates despite poor compliance 1999
    1999 Mechanical failure of the latex condom in a cohort of women at high STD risk 1999
    1999 Mucosal immunity in the genital tract: Prospects for vaccines against sexually transmitted diseases. A review 1999
    1999 Prospective study of barrier contraception for the prevention of sexually transmitted diseases: Study design and general characteristics of the study group 1999
    1999 The rapid test paradox: When fewer cases detected lead to more cases treated: A decision analysis of tests for Chlamydia trachomatis 1999
    1998 Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease- inhibitory activity in human female genital infection with Neisseria gonorrhoeae 1998
    1998 Is elimination of endemic syphilis transmission a realistic goal for the USA? 1998
    1998 Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection 1998
    1998 Evaluation of the biostar chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic 1998
    1998 Feasibility of obtaining sexual risk and STD history in the context of a drinking drivers' program 1998
    1998 Urine-based screening of adolescents in detention to guide treatment for gonococcal and chlamydial infections: Translating research into intervention 1998
    1998 Compliance with doxycycline therapy in sexually transmitted diseases clinics 1998
    1998 Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: Effects of concomitant infections 1998
    1998 Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection. 1998
    1998 HIV vaccine acceptance among heterosexual clients of a sexually transmitted diseases clinic 1998
    1998 Is elimination of endemic syphilis transmission a realistic goal for the USA? 1998
    1998 Modulation of immunologic responses to HIV-1(MN) recombinant gp160 vaccine by dose and schedule of administration 1998
    1997 Grepafloxacin versus cefixime as single-dose therapy for uncomplicated gonorrhea in women 1997
    1997 Patients attending STD clinics in an evolving health care environment: Demographics, insurance coverage, preferences for STD services, and STD morbidity 1997
    1997 Delayed presentation to clinics for sexually transmitted diseases by symptomatic patients: A potential contributor to continuing STD morbidity 1997
    1997 Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs 1997
    1997 Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men 1997
    1997 Definitions of genital ulcer disease and variation in risk for prevalent human immunodeficiency virus infection 1997
    1997 Diagnosis of Neisseria gonorrhoeae infections in women by using the ligase chain reaction on patient-obtained vaginal swabs 1997
    1997 High prevalence of chlamydia trachomatis infections in adolescent females not having pelvic examinations: Utility of PCR-based urine screening in urban adolescent clinic setting 1997
    1997 Self- treatment patterns among clients attending sexually transmitted disease clinics and the effect of self-treatment on STD symptom duration 1997
    1997 Antimicrobial resistance in Neisseria genorrhoeae in the United States, 1988-1994: The emergence of decreased susceptibility to the fluoroquinolones 1997
    1997 Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic 1997
    1997 Spontaneous clearance of chlamydia trachomatis infection in untreated patients 1997
    1996 Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships 1996
    1996 Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains 1996
    1996 Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines 1996
    1996 Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea 1996
    1996 Reactive arthritis in patients attending an urban sexually transmitted diseases clinic 1996
    1996 Prevalence of fluorescent monoclonal antibody-nonreactive Neisseria gonorrhoeae in five North American sexually transmitted disease clinics 1996
    1996 Chlamydial cervicitis and urethritis: Single dose treatment compared with doxycycline for seven days in community based practises 1996
    1996 Chlamydial cervicitis and urethritis: Single dose treatment compared with doxycycline for seven days in community based practises 1996
    1996 Biomedical issues in syphilis control 1996
    1996 PCR-based urine screening for chlamydia in females: Utility in an urban adolescent clinic setting 1996
    1995 Azithromycin for Empirical Treatment of the Nongonococcal Urethritis Syndrome in Men: A Randomized Double-blind Study 1995
    1995 Lumbar Puncture for Evaluation of Latent Syphilis in Hospitalized Patients: High Prevalence of Cerebrospinal Fluid Abnormalities Unrelated to Syphilis 1995
    1995 Sensitivity of Rapid Antigen Detection Tests for Chlamydia trachomatis Screening 1995
    1995 Cerebrospinal Fluid Treponemal Antibodies in Untreated Early Syphilis 1995
    1995 Condom use to prevent incident stds: The validity of self-reported condom use 1995
    1995 Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic 1995
    1995 Laboratory to laboratory variation in chlamydia trachomatis culture practices 1995
    1995 Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs 1995
    1994 Neurosyphilis 1994
    1994 Preface 1994
    1994 Use of Cell Culture and a Rapid Diagnostic Assay for Chlamydia trachomatis Screening 1994
    1994 Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection 1994
    1994 Development of sexually transmitted diseases treatment guidelines, 1993. New methods, recommendations, and research priorities. STD Treatment Guidelines Project Team and Consultants. 1994
    1994 Diagnosing neurosyphilis. 1994
    1994 Seroconversion in patients attending sexually transmitted disease clinics 1994
    1994 Alcohol and other substance use in std clinic patients: Relationships with stds and prevalent hiv infection 1994
    1994 Association of hepatitis c virus infection with false-positive tests for syphilis 1994
    1994 Characterization of patients accepting and refusing routine, voluntary hiv antibody testing in public sexually transmitted disease clinics 1994
    1994 Editorial response: Diagnosing neurosyphilis 1994
    1994 Efficacy of 250 mg trospectomycin sulfate im vs. 250 mg ceftriaxone im for treatment of uncomplicated gonorrhea 1994
    1994 Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men 1994
    1994 Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases 1994
    1994 Routine serologic screening for syphilis in hospitalized patients: High prevalence of unsuspected infection in the elderly 1994
    1993 Preface 1993
    1993 Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women 1993
    1993 Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea 1993
    1993 Transmission of Chlamydia trachomatis among Sex Partners Assessed by Polymerase Chain Reaction 1993
    1992 Acquired Syphilis in Adults 1992
    1992 Comparative behavioral epidemiology of gonococcal and chlamydial infections among patients attending a baltimore Maryland, sexually transmitted disease clinic 1992
    1992 Acquired syphilis in adults 1992
    1992 Effect of HIV Posttest Counseling on STD Incidence 1992
    1992 Association of Biologic False-Positive Reactions for Syphilis with Human Immunodeficiency Virus Infection 1992
    1992 Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit 1992
    1992 Evolution of the Human Immunodeficiency Virus Epidemic among Patients Attending Sexually Transmitted Disease Clinics: A Decade of Experience 1992
    1992 Gene typing of chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion 1992
    1992 Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals 1992
    1992 Infection with human t lymphotropic virus types i and ii in sexually transmitted disease clinics in Baltimore and New Orleans 1992
    1992 Management of syphilis in human immunodeficiency virus-infected patients 1992
    1992 Nonculture tests for genital tract chlamydial infection: What does the package insert mean, and will it mean the same thing tomorrow? 1992
    1992 Prevalence and patterns of condom use among patients attending a sexually transmitted disease clinic 1992
    1992 Prevalence and patterns of condom use among patients attending a sexually transmitted disease clinic 1992
    1992 Temporal trends in gonococcal antibiotic resistance in baltimore 1992
    1991 Interpartner reliability of reporting of recent sexual behaviors 1991
    1991 A Comparison of Single-Dose Cefixime with Ceftriaxone as Treatment for Uncomplicated Gonorrhea 1991
    1991 CD4 Lymphocyte Concentrations in Patients With Newly Identified HIV Infection Attending STD Clinics: Potential Impact on Publicly Funded Health Care Resources 1991
    1991 An experimental model of early central nervous system syphilis 1991
    1991 Characteristics of Patients With Syphilis Attending Baltimore STD Clinics: Multiple High-Risk Subgroups and Interactions With Human Immunodeficiency Virus Infection 1991
    1991 Cocaine hydrochloride and benzoylecgonine have no in vitro inhibitory effect against Neisseria gonorrhoeae 1991
    1991 Genital human papillomavirus infections in patients attending an inner-city STD clinic. 1991
    1991 Sexually transmitted diseases in a population of intravenous drug users: Association with seropositivity to the human immunodeficiency virus (hiv) 1991
    1991 Surrogate methods to diagnose gonococcal and chlamydial cervicitis: Comparison of leukocyte esterase dipstick, endocervical gram stain, and culture 1991
    1990 National Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae 1990
    1990 National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. 1990
    1990 Clinical conundrum 1990
    1990 Septic gonococcal arthritis is much more common in the USA than in the UK. 1990
    1990 Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens 1990
    1990 The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics 1990
    1990 Behavioral contributions to acquisition of gonorrhea in patients attending an inner city sexually transmitted disease clinic 1990
    1990 Behavioral relapse among homosexually active men: Implications for std control 1990
    1990 Discussion about septic arthritis with American colleagues leads inescapably to the conclusion that gonococcal arthritis is much more common in the USA than in the UK. Is it the strain of organism, differences in lifestyles or what? 1990
    1990 Evaluation of abbott test pack® chlamydia for detection of chlamydia trachomatis in patients attending sexually transmitteddiseases clinics 1990
    1990 Reproductive health practices in women attending an inner-city std clinic 1990
    1990 Routine voluntary hiv screening in std clinic clients: Characterization of infected clients 1990
    1990 Routine voluntary hiv screening in std clinic clients: Characterization of infected clients 1990
    1990 Skin and soft-tissue infections: Editorial Overview 1990
    1990 Syphilis in adults 1990
    1989 Comparison of GC-Lect and modified Thayer-Martin media for isolation of Neisseria gonorrhoeae 1989
    1989 Determinants Of Emergence Of Antibiotic-Resistant Neisseria Gonorrhoeae 1989
    1989 HTLV-I and HIV-1-associated neurologic abnormalities; syphilis as a confounding factor 1989
    1989 Health care needs of the adolescent 1989
    1989 Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection 1989
    1989 Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea 1989
    1989 Syphilis and HIV Infection 1989
    1989 Treatment of syphilis: Current recommendations, alternatives, and continuing problems 1989
    1988 Screening for HIV Infection in Sexually Transmitted Disease Clinics 1988
    1988 Human Immunodeficiency Virus Infection among Patients Attending Clinics for Sexually Transmitted Diseases 1988
    1988 Ceftriaxone therapy for incubating and early syphilis 1988
    1988 Improving medical education in therapeutics 1988
    1988 Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment 1988
    1988 Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults 1988
    1988 The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus (HIV) 1988
    1988 The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus (HIV) 1988
    1988 Treatment of uncomplicated gonorrhea with single-dose imipenem-cilastatin 1988
    1987 Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures 1987
    1987 Human immunoglobulin G antibody response to the major gonococcal iron-regulated protein 1987
    1987 The acute arthritis-dermatitis syndrome. The changing importance of Neisseria gonorrhoeae and Neisseria meningitidis 1987
    1987 Gonococcal infections. 1987
    1987 Acute Cellulitis 1987
    1987 Auxotype/serovar diversity and antimicrobial resistance of neisseria gonorrhoeae in two mid-sized american cities 1987
    1987 Ceftriaxone for treatment of uncomplicated gonorrhea: Routine use of a single 125-mg dose in a sexually transmitted disease clinic 1987
    1987 Contraceptive needs and practices among women attending an inner-city STD clinic 1987
    1987 Detection of treponema pallidum by a fluorescent monoclonal antibody test 1987
    1987 Epidemiology of gonorrhea: Distribution and temporal changes in auxotype/serovar classes of neisseria gonorrhoeae 1987
    1987 Gonococcal infections: A continuing diagnostic and therapeutic challenge 1987
    1986 Microbiologic evaluation of cutaneous cellulitis in adults 1986
    1986 Laboratory evaluation of sexually transmitted diseases. 1986
    1986 Ceftriaxone therapy for asymptomatic neurosyphilis: Case report and western blot analysis of serum and cerebrospinal fluid IgG response to therapy 1986
    1986 Comparative study of cefoperazone and spectinomycin for treatment of uncomplicated gonorrhea in men 1986
    1986 Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men 1986
    1986 Dose ranging study of cefpimizole (U-63196E) for treatment of uncomplicated gonorrhea in men 1986
    1985 Detection of Treponema pallidum in lesion exudate with a pathogen-specific monoclonal antibody 1985
    1985 Antigens of treponema pallidum recognized by igg and igm antibodies during syphilis in humans 1985
    1985 Gonococcal infections 1985
    1985 Occupational Exposure to Hepatitis B in Paramedics 1985
    1984 Serogrouping of neisseria gonorrhoeae: Correlation of serogroup with disseminated gonococcal infection 1984
    1983 Failure of Intensive Care Unit Support to Influence Mortality From Pneumococcal Bacteremia 1983
    1983 Sexually transmitted diseases in men 1983
    1982 Congenital malaria: A report of four cases and a review 1982
    1982 Disseminated gonococcal infection 1982
    1980 Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. 1980
    1978 Vancomycin therapy of bacterial endocarditis 1978
    1977 The management of gonorrhea in an emergency room. 1977
    1976 A Trichomonas Species in a Mixed Microbial Meningitis 1976
    1976 Comparative effect of penicillin G and ampicillin with streptomycin in enterococcal endocarditis 1976
    1975 Antimicrobial therapy of experimental enterococcal endocarditis 1975
    1975 Antimicrobial therapy of experimental enterococcal endocarditis 1975
    1975 Medical grand rounds: from the Department of Medicine, University of Virginia Medical Center: The evaluation of pleural effusions. 1975
    1974 Role of the vegetation in experimental Streptococcus viridans endocarditis 1974
    1974 Medical Grand Rounds: from the Department of Medicine, University of Virginia Medical Center: Nephrolithiasis. 1974
    1969 Leukocyte function in chronic granulomatous disease of childhood. Studies on a seventeen year old boy 1969
    1965 Changing patterns of bacterial resistance to antimicrobial drugs 1965
    1962 Prophylaxis of bacterial endocarditis 1962
    1960 An epizootic in swiss mice caused by a group a streptococcus, newly designated type 50 1960

    Chapter

    Year Title Altmetric
    2015 Immunity to Sexually Transmitted Infections.  2183-2214. 2015
    2014 Endemic Treponematoses.  2710-2713.e1. 2014
    2013 Chlamydia control: A comparative review from the USA and UK.  401-430. 2013
    2011 Nonsyphilitic Treponematoses.  1929-1930. 2011
    2011 Syphilis.  1922-1929. 2011
    2009 Gonorrhea.  963-981. 2009
    2006 Treponemal Infections.  492-498. 2006
    2005 Mucosal immunology of sexually transmitted diseases.  1693-1720. 2005

    Research Overview

  • Dr. Hook’s laboratory has emphasized diagnostic testing for Neisseria gonorrhoeae, Chlamydia trachomatis and syphilis, providing a platform for a wide variety of studies. His laboratory is one of 5 CDC-funded reference laboratories for the Gonococcal Isolate Surveillance Project which has monitored trends in gonococcal epidemiology and antimicrobial resistance in the U.S. since 1988. In addition, data generated by his and Dr. Schwebke’s laboratories (see below) has reflected collaboration with other faculty of the Infectious Diseases Division and other Departments within the School of Medicine (Obstetrics and Gynecology, Pediatrics and Microbiology) and other UAB Schools (Public Health, Social and Behavioral Sciences). Dr. Hook’s recent work has included: studies of health behavior and behavioral interventions for STD/HIV risk reduction; assessment of STD epidemiology; clinical trials of new therapeutic agents; and clinical evaluation of new diagnostic tests for diagnosis of gonorrhea, chlamydial infection and syphilis. Major ongoing research efforts include his role as PI on a randomized trial evaluation of non-invasive screening for gonococcal and chlamydial infections in adolescents seeking care at hospital emergency rooms and as Protocol Chair for a randomized trial evaluation of azithromycin for treatment of syphilis. Dr. Hook’s research is currently supported thought UAB’s multi-project NIAID-funded STD CRC (PI, E. W. Hook), the NIAID-funded STD Clinical Trials Unit (CTU) [M. Cohen, UNC PI, E. W. Hook, Co-PI), and several other grants from NIH and the CDC.

    • Principal Investigator On

  • Admin Core: Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200001 Task Area 1 Task Order 1 - Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200002 Task Area 1 Task Order 2 Kick-off Meeting: Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200003 Task Area 2 Task Order 1 - Clinical Trial Implementation-DMID (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200004 Task Area 2 Task Order 2 - Case Control Study Implementation (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200006 Task Area 1 Task Order 4 - Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200007 Task Area 2 Task Order 5 - Clinical Trial Modification and Implementation - DMID Protocol #07-0012  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200008 Task Area 1 Task Order 8 - Protocol Development, Implementation and Analysis for A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200009 Task Area 1 Task Order 7 - Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200010 Task Area 1 Task Order 9 - Sexually Transmitted Infections Clinical Trials Group (STI CTG) TASK AREA 1 TASK ORDER 9 Protocol Development, Implementation and Analysis for Mycoplasma Genitalium Among Men with Urethritis Attending STD Clinics in the US: Assessing Burden, Risk Factors and Co-Infections  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200011 Task Area 1 Task Order 10 - Sexually Transmitted Infections Clinical Trials Group (STI CTG) TASK AREA 1 TASK ORDER 10 Protocol Development, Implementation and Analysis for Treatment of Gardnerella Vaginalis Vaginal Colonization with Amoxicillin  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200012 Task Area 1 Task Order 11 - Overall Admin and Support Activities for the STI CTG to Include Procedures to Identify, Discuss and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200013 TA2 TO7 Sexually Transmitted Infections Clinical Trials Group (STI CTG) - STI-CTG Task Area 2 Task Order 7 Protocol Development, Implementation and Analysis for a Randomized Controlled Trial of Azithromycin Versus Doxycycline for the Treatment of Rectal Chlamydia in Men who have Sex with Men  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200014 TA2 TO8 HHSN27220130012I Task Area 2 Task Order 8 - A Phase III Comparative Trial of Benzathine Penicillin G, 2.4 Million Units Administered as a Single Dose Versus Three Sucessive Weekly Doses for Treatment of Early Syphilis in Persons with and without HIV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200015 TA1 TO13 STI CTG Task Area 1 Task Order 13: Protocol Development, Implementation and Analysis for Development and Validating an Easy to Administer Instrument to Define Penicillin (B-lactam) Allergy Status in STD Outpatients  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200016 TA1 TO 14 Task Area 1 Task Order 14: A Randomized, Placebo-Controlled Trial of TOL-463 for Suppression of Bacterial Vaginosis (BV)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • The UAB STI CRC - DiSCIS Administrative Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • The UAB STI CRC - Project 1: Determining the Origins of NGU in Men Through Evaluation of Sexual Partnerships  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Alabama/North Carolina STD/HIV Prevention Training Center Component A  awarded by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 2014 - 2020
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2017 - 2018
  • Private Grant  awarded by HOLOGIC, INC. 2017 - 2018
  • Gonococcal Isolate Surveillance Project  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2014 - 2017
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2016 - 2017
  • Private Grant  awarded by HOLOGIC, INC. 2016 - 2017
  • Private Grant  awarded by ROCHE DIAGNOSTICS OPERATIONS INC 2016 - 2017
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2015 - 2016
  • Private Grant  awarded by QUEST DIAGNOSTICS, INC. 2015 - 2016
  • Private Grant  awarded by BD DIAGNOSTICS 2013 - 2016
  • Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing: Concurrence in Non-Clinical Settings vs. Clinical Settings  awarded by University of California, San Francisco 2014 - 2015
  • Private Grant  awarded by MELINTA THERAPEUTICS, INC. 2014 - 2015
  • Private Grant  awarded by MERCK & COMPANY, INC. 2015
  • JCDH Contract NO: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2014 - 2015
  • Private Grant  awarded by BD DIAGNOSTICS 2012 - 2015
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2013 - 2015
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2004 - 2015
  • Private Grant  awarded by GlaxoSmithKline 2014 - 2015
  • Private Grant  awarded by CEMPRA PHARMACEUTICALS, INC. 2012 - 2015
  • Jefferson County Department of Health Contract No. DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2012 - 2014
  • STD/HIV Prevention Training Center  awarded by CDC - NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION 2011 - 2014
  • Private Grant  awarded by BD DIAGNOSTICS 2011 - 2014
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2012 - 2014
  • Private Grant  awarded by BD DIAGNOSTICS 2012 - 2014
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2013 - 2014
  • Private Grant  awarded by CEPHEID 2011 - 2013
  • Gonococcal Isolate Surveillance Project (GISP) Regional Laboratories  awarded by CDC - NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION 2009 - 2013
  • Private Grant  awarded by GEN-PROBE, INC. 2012 - 2013
  • AIDS Education & Training Centers Florida/Caribbean AIDS Education and Training Center (AETC)  awarded by UNIVERSITY OF SOUTH FLORIDA 2011 - 2013
  • Private Grant  awarded by BD DIAGNOSTICS 2009 - 2013
  • Private Grant  awarded by CEPHEID 2010 - 2013
  • Private Grant  awarded by GlaxoSmithKline 2008 - 2012
  • JCDH Contract No DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2011 - 2012
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2010 - 2012
  • Private Grant  awarded by BD DIAGNOSTICS 2009 - 2012
  • Private Grant  awarded by SIEMENS HEALTHCARE DIAGNOSTICS, INC. 2010 - 2011
  • JCDH Contract No DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2010 - 2011
  • Herpevac Trial for Women  awarded by Saint Louis University 2002 - 2011
  • HIV Training Through Prevention Training Centers  awarded by Johns Hopkins University 2010 - 2011
  • Sexually Transmitted Diseases/Human Immunodeficiency Virus Prevention Training Center  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2008 - 2011
  • Private Grant  awarded by GEN-PROBE, INC. 2009 - 2010
  • Private Grant  awarded by SIEMENS MEDICAL SOLUTIONS, INC. 2008 - 2010
  • JCDH Contract No. DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2009 - 2010

    • Investigator On

  • Private Grant  awarded by LUPIN INC. 2019 - 2021
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T016 HHSN27200014 TA2 TO8 A Phase III Comparative Trial of Benzathine Penicillin G, 2.4 Million Units Administered as a Single Dose Versus Three Sucessive Weekly Doses for Treatment of Early Syphilis in Persons with and without HIV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • Private Grant  awarded by ABBOTT MOLECULAR 2018 - 2020
  • HHSN27200005 Task Area 1 Task Order 5 - Protocol Development for "Clearance Time of Gonococcal Nucleic Acid by Nucleic Acid Amplification Testing" (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • Private Grant  awarded by NEUMODX MOLECULAR 2019 - 2020
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • The UAB STI CRC - DiSCIS Clinical Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Pathogenesis of Bacterial Vaginosis in Women Who Have Sex with Women  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Private Grant  awarded by SPEEDX PTY. LTD. 2018 - 2020
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY 2019 - 2020
  • Rectal and Oropharyngeal Swabs to Diagnose Gonococcal and Chlamydial Infection in Men and Women  awarded by University of California, San Francisco 2018 - 2020
  • Private Grant  awarded by CEPHEID 2018 - 2019
  • Private Grant  awarded by RHEONIX, INC. 2014 - 2019
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2018 - 2019
  • Private Grant  awarded by ATLAS GENETICS 2017 - 2019
  • UAB Center for Clinical and Translational Science (CCTS) (3 Linked Awards UL1, KL2, TL1)  awarded by National Center for Advancing Translational Sciences/NIH/DHHS 2015 - 2019
  • The UAB Infectious Diseases Training Grant  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by LUMINEX CORPORATION 2018 - 2019
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2017 - 2018
  • Private Grant  awarded by ABBOTT MOLECULAR 2018
  • Private Grant  awarded by CLICK DIAGNOSTICS 2016 - 2018
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY 2016 - 2018
  • Trichomonas Vaginalis Repeat Infections Among HIV-Negative Women  awarded by TULANE UNIVERSITY 2013 - 2018
  • Private Grant  awarded by CURATEK PHARMACEUTICALS 2015 - 2018
  • Private Grant  awarded by LUMINEX CORPORATION 2017
  • Private Grant  awarded by BECKMAN COULTER, INC. 2015 - 2017
  • Mechanisms and Correlates of Immune Protection Against Genital Chlamydia in Humans  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2017
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2016 - 2017
  • Private Grant  awarded by LABORATORY CORPORATION OF AMERICA HOLDINGS 2016 - 2017
  • Private Grant  awarded by STARPHARMA 2014 - 2017
  • Inhibition of Herpes Simplex Viruses Type 2 by Tenofovir  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2012 - 2017
  • Private Grant  awarded by BD DIAGNOSTICS 2015 - 2017
  • Private Grant  awarded by FLORA BIOSCIENCE 2016 - 2017
  • Private Grant  awarded by HOLOGIC, INC. 2014 - 2016
  • Private Grant  awarded by VIAMET PHARMACEUTICALS, INC. - NEW 2014 - 2016
  • Private Grant  awarded by ELITECH GROUP MOLECULAR 2014 - 2016
  • Private Grant  awarded by QUIDEL CORPORATION 2015 - 2016
  • Private Grant  awarded by CEPHEID 2014 - 2016
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2015
  • Private Grant  awarded by BIOHELIX CORPORATION 2013 - 2015
  • Private Grant  awarded by ROCHE DIAGNOSTICS OPERATIONS INC 2014 - 2015
  • Private Grant  awarded by BD DIAGNOSTICS 2014 - 2015
  • Private Grant  awarded by ACTIVBIOTICS, INC. 2012 - 2014
  • Private Grant  awarded by HOLOGIC, INC. 2014
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2014
  • Private Grant  awarded by GENOCEA BIOSCIENCES, INC. 2012 - 2014
  • Private Grant  awarded by CEPHEID 2013 - 2014
  • CITY Health - Center for the Study of Community Health SIP 11-048: Case Control Study of Chlamydia and Infertility Among Women Assessed for Tubal Disease or Treated by Assisted Reproductive Technology  awarded by National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS 2011 - 2014
  • CITY Health - Center for Study of Community Health  awarded by National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS 2009 - 2014
  • Private Grant  awarded by GEN-PROBE, INC. 2013 - 2014
  • Private Grant  awarded by CEPHEID 2014
  • Private Grant  awarded by COPAN DIAGNOSTICS, INC 2012 - 2013
  • Private Grant  awarded by SANOFI PASTEUR LIMITED 2009 - 2013
  • Private Grant  awarded by WARNER CHILCOTT 2010 - 2013
  • Private Grant  awarded by MEDICIS PHARMACEUTICAL CORPORATION 2012 - 2013
  • Private Grant  awarded by BD DIAGNOSTICS 2011 - 2013

    • Education And Training

  • University of Washington Medical Center, Internship 1977
  • University of Washington Medical Center, Residency 1980
  • University of Washington Medical Center, Postdoctoral Fellowship 1983

    • Full Name

  • Edward Hook